Filter your results
- 3
- 1
- 4
- 4
- 2
- 1
- 1
- 1
- 1
- 1
- 4
- 4
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-alpha antagonist therapy: safe re-initiation of TNF-alpha blockers after appropriate anti-tuberculous treatment.Clinical Microbiology and Infection, 2008, 14 (2), pp.183-186. ⟨10.1111/j.1469-0691.2007.01891.x⟩
Journal articles
inserm-00217468v1
|
||
|
Bone events and evolution of biologic markers in Gaucher disease before and during treatment.Arthritis Research and Therapy, 2010, 12 (4), pp.R156. ⟨10.1186/ar3111⟩
Journal articles
inserm-00544232v1
|
||
Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 studyLiver International, 2015, 35 (8), pp.1950-1958. ⟨10.1111/liv.12777⟩
Journal articles
istex
hal-02637622v1
|
|||
|
Ciprofloxacin Dosage and Emergence of Resistance in Human Commensal Bacteria.Journal of Infectious Diseases, 2009, 200 (3), pp.390-398. ⟨10.1086/600122⟩
Journal articles
inserm-00409776v1
|